<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00941239</url>
  </required_header>
  <id_info>
    <org_study_id>Met-LP 1007/06</org_study_id>
    <nct_id>NCT00941239</nct_id>
  </id_info>
  <brief_title>Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)</brief_title>
  <official_title>Gastric Tolerability and Pharmacokinetics of an Extended Release Metformin and an Immediate Release Metformin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratorios Silanes S.A. de C.V.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratorios Silanes S.A. de C.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the gastric tolerability and the pharmacokinetics
      of an extended release metformin compared with an immediate release metformin in healthy
      subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasmatic drug concentration</measure>
    <time_frame>48 hours (7.5, 15,30,45,60,75,90,120,150,180,205,240,360,480,600,720,1440,2880 min and days : 3,5,7,14,21,28,30,35)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lanza score</measure>
    <time_frame>30 days (0 and 30)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasmatic glucose</measure>
    <time_frame>30 days (0, 6, 12 and 18 hours and days: 2,5,7,14,21,28,30 and 35)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>30 days (days: 0, 14 and 30)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>metformin ER</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extended Release Metformin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metformin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Immediate release metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metformin ER</intervention_name>
    <description>850mg daily for 30 days</description>
    <arm_group_label>metformin ER</arm_group_label>
    <other_name>predial plus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metformin</intervention_name>
    <description>850 mg daily for 30 days</description>
    <arm_group_label>metformin</arm_group_label>
    <other_name>extended release predial plus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mexican healthy subjects with normal clinical laboratory test results and imaging
             (hematology, blood chemistry, urine test, VDRL, Hepatitis B, HIV, chest radiography
             and electrocardiogram)

        Exclusion Criteria:

          -  Familiar or personal history of diabetes

          -  History of drug or alcohol abuse within the 2 years prior to the study

          -  A smoking habit greater than 10 cigarettes per day

          -  History of allergy to the study drugs

          -  Intercurrent disease

          -  Intercurrent treatment with any drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oscar Torres, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>UANL, Pharmacology and toxicology department</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge A Gonzalez</last_name>
    <role>Study Director</role>
    <affiliation>Laboratorios Silanes S.A. de C.V.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pharmacology and toxicology department, UANL</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Le√≥n</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Curr Med Res Opin. 2004 Apr;20(4):565-72.</citation>
    <PMID>15119994</PMID>
  </reference>
  <reference>
    <citation>Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF. Transfer of metformin into human milk. Diabetologia. 2002 Nov;45(11):1509-14. Epub 2002 Sep 25.</citation>
    <PMID>12436333</PMID>
  </reference>
  <reference>
    <citation>Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 Aug 31;333(9):550-4.</citation>
    <PMID>7623903</PMID>
  </reference>
  <reference>
    <citation>Brown BW Jr. The crossover experiment for clinical trials. Biometrics. 1980 Mar;36(1):69-79.</citation>
    <PMID>7370374</PMID>
  </reference>
  <reference>
    <citation>Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80.</citation>
    <PMID>3450848</PMID>
  </reference>
  <reference>
    <citation>Westlake WJ. Symmetrical confidence intervals for bioequivalence trials. Biometrics. 1976 Dec;32(4):741-4.</citation>
    <PMID>1009222</PMID>
  </reference>
  <reference>
    <citation>The United States Pharmacopeia USP26. Pags 525-526. 2003. Rockville. MD.</citation>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2009</study_first_submitted>
  <study_first_submitted_qc>July 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2009</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Metformin ER</keyword>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Tolerability</keyword>
  <keyword>Healthy volunteers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

